I’d been listening on and off all day to tributes from the great and good, but tops for me was a barmaid this evening at the Norfolk Arms in Ringinglowe. “No one had a bad word to say about him”, … Read More »
In a characteristically witty email today, my pal Mick shared his horror at realising he agreed with something Hitchens had written in the Quail on Sunday. Relax Michael. It’s cognitive dissonance makes us uncomfy when people with views we detest … Read More »
If I hadn’t spent my Xmas/New Year gap week in Copenhagen I’d probably have filed Danish Girl – man discovers he’s a woman trapped in the wrong body – under Worthy-but-Dull and given it a miss. So I’m now doubly … Read More »
[ezcol_1half] [/ezcol_1half] [ezcol_1half_end]Michael White’s Guardian piece yesterday … do give it a read and tell me if and when, in any newspaper alleged to be ‘quality’, you ever saw anything so crass and childish. White contrasts the “tough” north – … Read More »
Dylan Avery made four versions of Loose Change, setting out the ‘Truther’ case for 9/11 as an inside job to legitimate Bush-Cheney’s middle east capers. I saw the first cut twice, thought it tripe and still do. Why? False flag … Read More »
This from Twitter yesterday …
In today’s Guardian, political editor Toby Helm anticipates the replacement of Hilary Benn and Maria Eagle in an imminent reshuffle by Jeremy Corbyn. Such a reshuffle, Helm tells us, would be “high risk”; one likely outcome being the resignation of … Read More »
[ezcol_1half]Because they hang onto my every word, so know every detail of my passion for photography, down to the mid focal length gap in my lens collection, and because they love and admire me so, Rhianna (18) and Charis (15) … Read More »
[ezcol_1half][/ezcol_1half] [ezcol_1half_end]I saw this, originating in the New Yorker, on FB just this morning. An Escher admirer for forty years and more, how could I resist? We don’t need this information to appreciate the New Yorker humour but as it … Read More »
[ezcol_1half][/ezcol_1half] [ezcol_1half_end]Remember Martin Shrkeli? He launched Retrophin, a company that acquired rights to drugs for rare diseases, then ramped up their prices. One example was Thiola, used to treat a disease causing kidney stones. After it came into the Retrophin … Read More »